The Abu Dhabi International Conference on Mental Health has announced that Khalifa Medical City has adopted a new protocol (a group of health-safe drugs) to treat the symptoms of drug withdrawal from the body of addictive patients, and constitutes eight times the success rate of the traditional protocol, in addition to a new treatment used by inhalation «Spray "For depression, it will be used in America, Europe and the UAE next April," he said, referring to the control of methamphetamine (crystal), the drug market, three years ago, and the decline of heroin, while the concentration of users between the ages of 20 to 40 years.
The three-day Abu Dhabi International Mental Health Conference, organized by Sheikh Khalifa Medical City in collaboration with the Ministry of Health and Community Protection, kicked off yesterday with the participation of 83 researchers from 15 countries, including 33 researchers from the UAE, in addition to more than 800 Doctor and specialist in the fields of psychiatry.
Dr. Tarek Darwish, Director of Medical Affairs at the Behavioral Sciences Pavilion, Dr. Tariq Darwish, Chairman of the Conference, said: “We suffer with patients who are not committed to treatment, especially in some diseases where the patient has a tendency to stop treatment early, so the trend is now to put medicines Long-acting injections began two weeks to compensate for daily medications, then increased to a month, and then became an injection every three months to treat schizophrenia.
He revealed a new anti-depressant drug inhalation (spray), which will be used in the UAE, and will be available in the country early next year, after obtaining the approval of the US Food and Drug Administration, and given to depressed patients who do not respond to regular medicines, which is fast-acting, starts to take effect during He pointed out that there are 30 types of depression, which is still the most prevalent mental illness, and represents 6% of mental disorders in the world, pointing out that this makes genetic research related to depression in particular, and mental illness in general, difficult, given To bifurcate.
The consultant of psychiatry, head of the addiction treatment unit at Khalifa Medical City, Dr. Mohammed Al-Jarhi, that the duration of treatment of the drug opium and its derivatives are longer and harder, compared to other narcotic substances, because of the severity of symptoms of withdrawal of the drug from the patient's body, compared to other types, pointing out that SKMC has developed a new method (therapeutic protocol) for the treatment of drug withdrawal symptoms, and has been approved by the ethical and professional research committee in the city, where the results of the application showed that it is effective and safe, and reduces the patient's resistance to medical advice, and exit from treatment before completion.
He pointed out that a specialized medical team from Sheikh Khalifa Medical City conducted research on 52 cases of treatment for withdrawal symptoms of addiction, and the results showed that a percentage of those treated through the new therapeutic protocol, succeeded in the withdrawal from the phase of medical advice.
The latest medical innovations
The Abu Dhabi International Conference on Mental Health has organized an exhibition of the latest medical innovations for the treatment of mental illnesses, which included a presentation of the new drug for the treatment of depression, Spravato spray provided by the manufacturer, which is a spray containing «narcotic drug» to treat depression, in cases where Other drugs fail to cure it, as the new drug will provide additional efficacy for treatment-resistant depression, which is considered a serious life-threatening condition.
Magdi Abdel Hamid, the Middle East marketing director of the drug manufacturer, said in a press statement that the new treatment has been approved by the US Food and Drug Administration after it proved effective, expecting the presence of the drug in the country next April, pointing out that the use of the new drug will be under the supervision of a doctor -It needs a prescription, being a controlled medication.